Background: Only a few studies have dealt with quantitative changes of Sertoli cells during human development, and the results of these studies are conflicting. Our hypothesis is that the development of Sertoli cells during mini-puberty follows the same pattern as germ cells. Methods: We examined the biopsies of cryptorchid and normal testes from patients aged 1–12 months. Fifty complete, rounded tubules were examined and the number of Sertoli cells per tubule was determined. We compared the numbers in cryptorchid and normal testes, as well as the average number of Sertoli cells in each age group separately. Results: The number of Sertoli cells per tubule in the cryptorchid testes of patients aged 1–4 months was 22.38 ± 1.01 compared to cryptorchid patients aged 5–12 months (23.20 ± 1.41). This number in patients with spontaneously descended testes aged 1–4 months was 23.53 ± 1.98, while this number in the same group of patients aged 5–12 months was 26.20 ± 1.40. The difference between the two age groups was statistically significant (p < 0.001, two-tailed test). Conclusions: Our results suggest the number of Sertoli cells increases with the hormonal surge. In cryptorchid patients, the number of Sertoli cells is diminished compared to the normal testis.

Keywords:
Cryptorchidism, Male fertility, Testis, Sertoli cells
This content is only available via PDF.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.